Development of antiviral fusion inhibitors: short modified peptides derived from the transmembrane glycoprotein of feline immunodeficiency virus.
about
A general strategy to endow natural fusion-protein-derived peptides with potent antiviral activityCholesterol-conjugated peptide antivirals: a path to a rapid response to emerging viral diseases.Aromatic amino acids in the juxtamembrane domain of severe acute respiratory syndrome coronavirus spike glycoprotein are important for receptor-dependent virus entry and cell-cell fusion.Cholesterol conjugation potentiates the antiviral activity of an HIV immunoadhesin.Interaction of short modified peptides deriving from glycoprotein gp36 of feline immunodeficiency virus with phospholipid membranes.Structural basis of antiviral activity of peptides from MPER of FIV gp36
P2860
Development of antiviral fusion inhibitors: short modified peptides derived from the transmembrane glycoprotein of feline immunodeficiency virus.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Development of antiviral fusio ...... feline immunodeficiency virus.
@en
Development of antiviral fusio ...... feline immunodeficiency virus.
@nl
type
label
Development of antiviral fusio ...... feline immunodeficiency virus.
@en
Development of antiviral fusio ...... feline immunodeficiency virus.
@nl
prefLabel
Development of antiviral fusio ...... feline immunodeficiency virus.
@en
Development of antiviral fusio ...... feline immunodeficiency virus.
@nl
P2093
P2860
P50
P356
P1433
P1476
Development of antiviral fusio ...... feline immunodeficiency virus.
@en
P2093
Anna Maria D'Ursi
Cinzia Esposito
Maria Claudia Alcaro
Maria Rosaria Armenante
Mauro Bendinelli
Olimpia Sichi
Simone Giannecchini
P2860
P304
P356
10.1002/CBIC.200500390
P577
2006-05-01T00:00:00Z